Literature DB >> 25917155

Evidence for traditional Chinese medication to treat cardiovascular disease.

Pan-Pan Hao1, Fan Jiang1, Yu-Guo Chen1, Jianmin Yang1, Kai Zhang1, Ming-Xiang Zhang1, Cheng Zhang1, Yu-Xia Zhao1, Yun Zhang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25917155     DOI： 10.1038/nrcardio.2014.177-c2

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  8 in total

1.  Integrating traditional Chinese medicine into Western cardiovascular medicine: an evidence-based approach.

Authors:  Xingjiang Xiong
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

Review 2.  Traditional Chinese medication for cardiovascular disease.

Authors:  Pan-Pan Hao; Fan Jiang; Yu-Guo Chen; Jianmin Yang; Kai Zhang; Ming-Xiang Zhang; Cheng Zhang; Yu-Xia Zhao; Yun Zhang
Journal:  Nat Rev Cardiol       Date:  2014-11-11       Impact factor: 32.419

3.  Prospective multicenter clinical trial of Chinese herbal formula JZQG (Jiangzhuoqinggan) for hypertension.

Authors:  Xiao-Lin Tong; Feng-Mei Lian; Qiang Zhou; Li-Peng Xu; Hang-Yu Ji; Gui-Cheng Xu; Yuan-Hui Hu; Lin-Hua Zhao; Le Xia; Jia Wang; Xin-Yan Chen; Man-Hon Chan; Lan-Lan Zhang; Wen Gao; Zhong Zhen; Shui-Ping Zhou; Bai Chang
Journal:  Am J Chin Med       Date:  2013       Impact factor: 4.667

4.  Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.

Authors:  Zongliang Lu; Wenrong Kou; Baomin Du; Yangfeng Wu; Shuiping Zhao; Osvaldo A Brusco; John M Morgan; David M Capuzzi; S Li
Journal:  Am J Cardiol       Date:  2008-04-11       Impact factor: 2.778

5.  Cardioankle vascular index evaluations revealed that cotreatment of ARB Antihypertension medication with traditional Chinese medicine improved arterial functionality.

Authors:  Yan Xu; Hua Yan; Min J Yao; Jie Ma; Jun M Jia; Fen X Ruan; Zeng C Yao; Hua M Huang; Jing Zheng; Ting Chen; Hua Lv; Alexander M Endler
Journal:  J Cardiovasc Pharmacol       Date:  2013-05       Impact factor: 3.105

Review 6.  Effects of traditional Chinese patent medicine on essential hypertension: a systematic review.

Authors:  Xingjiang Xiong; Pengqian Wang; Yuqing Zhang; Xiaoke Li
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

7.  Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter Study.

Authors:  Shao-Li Wang; Cheng-Long Wang; Pei-Li Wang; Hao Xu; Hong-Ying Liu; Jian-Peng Du; Da-Wu Zhang; Zhu-Ye Gao; Lei Zhang; Chang-Geng Fu; Shu-Zheng Lü; Shi-Jie You; Jun-Bo Ge; Tian-Chang Li; Xian Wang; Guan-Lin Yang; Hong-Xu Liu; Jing-Yuan Mao; Rui-Jie Li; Li-Dian Chen; Shu Lu; Da-Zhuo Shi; Ke-Ji Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-02       Impact factor: 2.629

8.  Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial.

Authors:  Hongcai Shang; Junhua Zhang; Chen Yao; Baoyan Liu; Xiumei Gao; Ming Ren; Hongbao Cao; Guohua Dai; Weiliang Weng; Sainan Zhu; Hui Wang; Hongjuan Xu; Boli Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-14       Impact factor: 2.629
  8 in total
  4 in total

1.  Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial.

Authors:  Ming Guo; Ming-Jie Zi; Rui-Xi Xi; Qiao-Ning Yang; Rui-Na Bai; Yi-Sheng Zhang; Yu-Hua Wang; Pei-Li Wang; Da-Zhuo Shi
Journal:  Trials       Date:  2016-08-18       Impact factor: 2.279

2.  Bioactive constituents of Salvia przewalskii and the molecular mechanism of its antihypoxia effects determined using quantitative proteomics.

Authors:  Yafeng Wang; Delong Duo; Yingjun Yan; Rongyue He; Shengbiao Wang; Aixia Wang; Xinan Wu
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

3.  Polypharmacological Profiles Underlying the Antitumor Property of Salvia miltiorrhiza Root (Danshen) Interfering with NOX-Dependent Neutrophil Extracellular Traps.

Authors:  Li Tao; Min Xu; Xiaojun Dai; Tengyang Ni; Dan Li; Feng Jin; Haibo Wang; Lide Tao; Bo Pan; James R Woodgett; Yayun Qian; Yanqing Liu
Journal:  Oxid Med Cell Longev       Date:  2018-08-19       Impact factor: 6.543

Review 4.  Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis.

Authors:  Tatiana V Kirichenko; Vasily N Sukhorukov; Alexander M Markin; Nikita G Nikiforov; Ping-Yen Liu; Igor A Sobenin; Vadim V Tarasov; Alexander N Orekhov; Gjumrakch Aliev
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.